Ann: Meluka Health to Develop Honey Water for Chinese Market, page-113

Many traders bumping the price up so we could free carry before Christmas was nice, I honestly was not expecting that till next year. The stock has played out basically how I said last few weeks with it heading up, sell off and retrace to 1.4-1.8. I was expecting profits to evaporate in the short term but am patient enough to see next year or 2019 for 5-10c if they roll out everything well and revenues keep increasing.

Theoretically The $3m could double or triple to $6-9m in revenue during 2018, followed by a massive push early 2019 from Cannabis based honey sales leading to a significant bump in share price.
Time will tell on that though, in the meantime I picked up on a co2-water-energy company an am trying to get into the ipo of lowy families new one market venture